News
AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...
13d
News-Medical.Net on MSNWhat happens if you significantly increase dietary folic acid intake?Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...
2monon MSN
Of 44 children with both autism and folate receptor alpha autoantibodies, two thirds treated with the drug showed language ...
According to the National Institutes of Health, about seven in 10 autistic children have folate receptor autoantibodies, a ...
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...
For example, when we inactivate (knock out) the folate receptor (Forl1) gene-its protein product which is a receptor molecule that brings vitamin B9 (folic acid) into cells is eliminated, and the ...
Role of Folate Receptor Alpha Testing Mirvetuximab soravtansine, an antibody-drug conjugate targeting FRα, represents the newest approved therapy in ovarian cancer. Testing considerations include ...
in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy. The U.S. Food and Drug Administration granted full approval to Elahere in ...
AbbVie's Elahere has been shown to reduce the risk of death in patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer by a third, reinforcing its blockbuster ...
AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically cleared for folate receptor-alpha (FRα) positive, platinum-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results